chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Nitrite urine absent, Oedema peripheral, Oesophagogastroduodenoscopy abnormal, Platelet count normal, Pleural thickening
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Post procedural haemorrhage, Protein total decreased, Protein urine, Pulmonary fibrosis, Red blood cell count decreased
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cells urine negative, Red cell distribution width increased, SARS-CoV-2 test positive, Specific gravity urine normal, Troponin I normal
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Urine ketone body absent, Urine leukocyte esterase, Urobilinogen urine, Walking aid user, White blood cell count decreased
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cells urine negative, pH urine normal
Clinical narrative: Narrative:  ASSESSMENT/PLAN: 1. Acute COVID - 19 infection in patient who has received 2 COVID vaccinations RA pulse ox 93-94% Start decadron Start remdesivir (LFTS are less than 5X wnl, GFR>30) 02 to keep sats >88% Albuterol MDI airborne precautions. 2. Mild acute hypoxic respiratory failure due to COVID 19 infection 02 to keep sats>88% continuous pulse ox 3. Right sided chest pain - related to fall/walker trauma - no rib fx on CXR or CT Incentive spirometry 4.Hx of multiple falls in the past, 2 falls in the past 24 hrs No head trauma or LOC Head CT negative for bleed/ischemia nonfocal neuro exam Neuro checks x 24 hrs PT/OT prior to discharge 5. Hx of CHF documented in the chart - but not by cardiology or EP. EF 55% on echo 2013 elevated BNP, bilateral lower edema on exam IV lasix Will order echo 6. Hx of PAF on apixaban, SSS s/p pacer, no evidence of active bleeding, hgb stable 7. Stage IIIA CKD - follow cr 8. Recent GI bleed s/p EGD 10/2021:no active bleeding but a small erosion in the distal body of the stomach, a clip was applied. Patient and wife deny any further bleeding hgb is stable cont PPI 9. HLD - hold crestor given elevated LFTS 10. DVT ppx- apixaban Day#8: S: Patient offers no complaints Denies cough or congestion 1. Acute COVID - 19 infection (s/p COVID vaccination x2, no booster) - improved S/P decadron and remdesivir x 5 days 02 to keep sats >92% Albuterol MDI airborne precautions Awaiting discharge
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient tested positive for Covid-19 and was hospitalized despite full vaccination of Moderna dose 1, 2, and booster which was given 11/10/2021. Hospitalized on 12/12/2021. COVID-19 (MODERNA), MRNA, LNP-S,* 3 11/10/2021 FACILITY* 2 04/02/2021 FACILITY* 1 03/00/2021 FACILITY*
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Cough, Dehydration, Diarrhoea
Clinical narrative: Narrative: Patient tested positive for Covid-19 and was hospitalized despite full vaccination of Pfizer 1st and 2nd dose, 2nd dose given 04/08/2021. Booster was not received. Admitted 11/12/21 hx DM2, bipolar, HTN, OSA, multiple DVTs on warfarin, presenting w/ 3 day history of malaise, cough, diarrhea, myalgias, starting 11/9. COVID+. Vaccinated x2 and on room air at current time. Patient was in his usual state of health until about 3 days ago (11/9) when he felt significant diffuse weakness and malaise. He also noted significant nausea, diarrhea (3-4x/day, non-bloody, no melena), and vomiting ( like water no blood or coffee grounds). He reports cough of yellow sputum, fevers up to 101F, and some dyspnea. Denies chest pain. Denies loss of taste or smell. Notably, he stopped taking all of his pills over the last few days, including his insulin and his warfarin. He lives with his wife who is also vaccinated and symptomatic, she is getting tested for COVID. He presented to ED for mAB infusion, which he received. However due to significant weakness and dehydration, hyperglycemia, decision made to admit to medicine for further monitoring and supportive care.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Hyperglycaemia, Malaise, Myalgia, Nausea
Clinical narrative: Narrative: Patient tested positive for Covid-19 and was hospitalized despite full vaccination of Pfizer 1st and 2nd dose, 2nd dose given 04/08/2021. Booster was not received. Admitted 11/12/21 hx DM2, bipolar, HTN, OSA, multiple DVTs on warfarin, presenting w/ 3 day history of malaise, cough, diarrhea, myalgias, starting 11/9. COVID+. Vaccinated x2 and on room air at current time. Patient was in his usual state of health until about 3 days ago (11/9) when he felt significant diffuse weakness and malaise. He also noted significant nausea, diarrhea (3-4x/day, non-bloody, no melena), and vomiting ( like water no blood or coffee grounds). He reports cough of yellow sputum, fevers up to 101F, and some dyspnea. Denies chest pain. Denies loss of taste or smell. Notably, he stopped taking all of his pills over the last few days, including his insulin and his warfarin. He lives with his wife who is also vaccinated and symptomatic, she is getting tested for COVID. He presented to ED for mAB infusion, which he received. However due to significant weakness and dehydration, hyperglycemia, decision made to admit to medicine for further monitoring and supportive care.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Productive cough, Pyrexia, SARS-CoV-2 test positive, Sputum discoloured, Vomiting
Clinical narrative: Narrative: Patient tested positive for Covid-19 and was hospitalized despite full vaccination of Pfizer 1st and 2nd dose, 2nd dose given 04/08/2021. Booster was not received. Admitted 11/12/21 hx DM2, bipolar, HTN, OSA, multiple DVTs on warfarin, presenting w/ 3 day history of malaise, cough, diarrhea, myalgias, starting 11/9. COVID+. Vaccinated x2 and on room air at current time. Patient was in his usual state of health until about 3 days ago (11/9) when he felt significant diffuse weakness and malaise. He also noted significant nausea, diarrhea (3-4x/day, non-bloody, no melena), and vomiting ( like water no blood or coffee grounds). He reports cough of yellow sputum, fevers up to 101F, and some dyspnea. Denies chest pain. Denies loss of taste or smell. Notably, he stopped taking all of his pills over the last few days, including his insulin and his warfarin. He lives with his wife who is also vaccinated and symptomatic, she is getting tested for COVID. He presented to ED for mAB infusion, which he received. However due to significant weakness and dehydration, hyperglycemia, decision made to admit to medicine for further monitoring and supportive care.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient tested positive for Covid-19 and was hospitalized despite full vaccination of J&J. Received vaccine on 4/8/21 and was hospitalized 11/22/21. Patient did not receive vaccine booster or additional doses.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient tested positive for COVID-19 and was hospitalized despite full vaccination (Pfizer dose 1 and 2). Hospitalized 11/23/21. Received dose #2 of vaccine on 2/24/21. No booster or 3rd vaccine dose received.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient tested positive for Covid-19 and was hospitalized despite full vaccination including booster (Pfizer 1,2,and booster). Vaccines received on 1/11/21, 2/4/21 and 12/2/21.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: SkinRash atypical hives all over her body for approximately 9 months Narrative: Developed atypical hives all over her body approximately 10 days after the second dose of the Pfizer vaccine, was evaluated by both a allergist and a dermatologist, which both identified the vaccine as the likely cause of the reaction. Mentioned it might be a form of serum sickness
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Asthenia, Atrial fibrillation, Blood magnesium increased
Clinical narrative: Narrative:  Patient died following 1 dose of COVID vaccine 02/10 COVID vaccine dose #1 02/12 admitted to ED with altered mental status, confusion, severe weakness, malnutrition; discharged to SNF 02/25 admitted to hospital from SNF due to respiratory distress, was intubated, BP to 74/50 03/08 pt remains admitted, supposed discharge 03/15 on hospice care 03/25 pt passed away, unknown cause Likely that COVID vaccine did not contribute to or cause patient's death, but was caused by advanced age (95 y/o) in combination with co-morbidities. Patient did not experience ADR to vaccine but was hospitalized 2 days later with weakness and confusion. Illness progressed until patient's death, but likely due to sepsis and pneumonia. No diagnosis of COVID noted.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Blood prolactin decreased, Brain natriuretic peptide increased, C-reactive protein increased, Computerised tomogram abdomen abnormal, Computerised tomogram head normal
Clinical narrative: Narrative:  Patient died following 1 dose of COVID vaccine 02/10 COVID vaccine dose #1 02/12 admitted to ED with altered mental status, confusion, severe weakness, malnutrition; discharged to SNF 02/25 admitted to hospital from SNF due to respiratory distress, was intubated, BP to 74/50 03/08 pt remains admitted, supposed discharge 03/15 on hospice care 03/25 pt passed away, unknown cause Likely that COVID vaccine did not contribute to or cause patient's death, but was caused by advanced age (95 y/o) in combination with co-morbidities. Patient did not experience ADR to vaccine but was hospitalized 2 days later with weakness and confusion. Illness progressed until patient's death, but likely due to sepsis and pneumonia. No diagnosis of COVID noted.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Death, Electrocardiogram abnormal, Endotracheal intubation, Haematocrit decreased
Clinical narrative: Narrative:  Patient died following 1 dose of COVID vaccine 02/10 COVID vaccine dose #1 02/12 admitted to ED with altered mental status, confusion, severe weakness, malnutrition; discharged to SNF 02/25 admitted to hospital from SNF due to respiratory distress, was intubated, BP to 74/50 03/08 pt remains admitted, supposed discharge 03/15 on hospice care 03/25 pt passed away, unknown cause Likely that COVID vaccine did not contribute to or cause patient's death, but was caused by advanced age (95 y/o) in combination with co-morbidities. Patient did not experience ADR to vaccine but was hospitalized 2 days later with weakness and confusion. Illness progressed until patient's death, but likely due to sepsis and pneumonia. No diagnosis of COVID noted.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Illness, Influenza A virus test negative, Influenza B virus test, Lung infiltration
Clinical narrative: Narrative:  Patient died following 1 dose of COVID vaccine 02/10 COVID vaccine dose #1 02/12 admitted to ED with altered mental status, confusion, severe weakness, malnutrition; discharged to SNF 02/25 admitted to hospital from SNF due to respiratory distress, was intubated, BP to 74/50 03/08 pt remains admitted, supposed discharge 03/15 on hospice care 03/25 pt passed away, unknown cause Likely that COVID vaccine did not contribute to or cause patient's death, but was caused by advanced age (95 y/o) in combination with co-morbidities. Patient did not experience ADR to vaccine but was hospitalized 2 days later with weakness and confusion. Illness progressed until patient's death, but likely due to sepsis and pneumonia. No diagnosis of COVID noted.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Malnutrition, Mental status changes, Platelet count decreased, Pleural effusion, Pneumonia
Clinical narrative: Narrative:  Patient died following 1 dose of COVID vaccine 02/10 COVID vaccine dose #1 02/12 admitted to ED with altered mental status, confusion, severe weakness, malnutrition; discharged to SNF 02/25 admitted to hospital from SNF due to respiratory distress, was intubated, BP to 74/50 03/08 pt remains admitted, supposed discharge 03/15 on hospice care 03/25 pt passed away, unknown cause Likely that COVID vaccine did not contribute to or cause patient's death, but was caused by advanced age (95 y/o) in combination with co-morbidities. Patient did not experience ADR to vaccine but was hospitalized 2 days later with weakness and confusion. Illness progressed until patient's death, but likely due to sepsis and pneumonia. No diagnosis of COVID noted.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory distress, Respiratory syncytial virus test negative, SARS-CoV-2 test negative, Sepsis, Troponin increased
Clinical narrative: Narrative:  Patient died following 1 dose of COVID vaccine 02/10 COVID vaccine dose #1 02/12 admitted to ED with altered mental status, confusion, severe weakness, malnutrition; discharged to SNF 02/25 admitted to hospital from SNF due to respiratory distress, was intubated, BP to 74/50 03/08 pt remains admitted, supposed discharge 03/15 on hospice care 03/25 pt passed away, unknown cause Likely that COVID vaccine did not contribute to or cause patient's death, but was caused by advanced age (95 y/o) in combination with co-morbidities. Patient did not experience ADR to vaccine but was hospitalized 2 days later with weakness and confusion. Illness progressed until patient's death, but likely due to sepsis and pneumonia. No diagnosis of COVID noted.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Urine analysis normal, White blood cell count increased
Clinical narrative: Narrative:  Patient died following 1 dose of COVID vaccine 02/10 COVID vaccine dose #1 02/12 admitted to ED with altered mental status, confusion, severe weakness, malnutrition; discharged to SNF 02/25 admitted to hospital from SNF due to respiratory distress, was intubated, BP to 74/50 03/08 pt remains admitted, supposed discharge 03/15 on hospice care 03/25 pt passed away, unknown cause Likely that COVID vaccine did not contribute to or cause patient's death, but was caused by advanced age (95 y/o) in combination with co-morbidities. Patient did not experience ADR to vaccine but was hospitalized 2 days later with weakness and confusion. Illness progressed until patient's death, but likely due to sepsis and pneumonia. No diagnosis of COVID noted.
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Malaise
Clinical narrative: Narrative:  Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt was 96 and on 2/25/21, his reported he was not doing well and was being place for hospice and not going to be able to get his second dose of his COVID vaccine. He passed on 3/25/21 without a documented cause of death. His comorbidities included advanced age, CAD, AAA, HTN, TIA, sick sinus syndrome and he had an ICD.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Incomplete course of vaccination
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Circumstances surrounding his death are not evident in chart. Patient missed his second COVID shot due to hospitalization at a facility sometime before his death on 3/12/21. Comorbidities include CAD, Afib, AAA, obesity, prostate cancer, advanced age, HTN.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Diagnostic aspiration, Malnutrition, Neoplasm malignant
Clinical narrative: Narrative:  Patient died after COVID vaccine dose #1 01/20 pt presents to ED with left neck swelling x 1 month, weight loss, coughing, left AMA before being seen by provider 02/10 seen by PCP for initial visit and sent to ED to evaluate neck mass, dizziness and neck pain upon standing, depressed and forgetful, hypophonia; CT HEAD/NECK showed neck mass, likely malignant, admitted 02/12 COVID vaccine dose #1 02/13 discharged from hospital, FNA showed advanced squamous cell carcinoma in neck 03/07 admitted to hospital due to malnourishment 03/10 pt enrolled in hospice care 03/28 pt passed away Death likely due to aggressive malignant carcinoma and not related to COVID vaccine. Patient was hospitalized before and after vaccination for comorbidities. Did not experience ADR at time of vaccination. Was never diagnosed with COVID infection.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Squamous cell carcinoma
Clinical narrative: Narrative:  Patient died after COVID vaccine dose #1 01/20 pt presents to ED with left neck swelling x 1 month, weight loss, coughing, left AMA before being seen by provider 02/10 seen by PCP for initial visit and sent to ED to evaluate neck mass, dizziness and neck pain upon standing, depressed and forgetful, hypophonia; CT HEAD/NECK showed neck mass, likely malignant, admitted 02/12 COVID vaccine dose #1 02/13 discharged from hospital, FNA showed advanced squamous cell carcinoma in neck 03/07 admitted to hospital due to malnourishment 03/10 pt enrolled in hospice care 03/28 pt passed away Death likely due to aggressive malignant carcinoma and not related to COVID vaccine. Patient was hospitalized before and after vaccination for comorbidities. Did not experience ADR at time of vaccination. Was never diagnosed with COVID infection.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood bicarbonate decreased, Blood creatinine increased, Blood gases abnormal, Blood lactic acid
Clinical narrative: Narrative:  Patient died after COVID vaccination dose #1. 11/06 hospitalization 12/20 hospitalization: COPD exacerbation with acute respiratory failure requiring bipap 12/29 hospitalization for SOB, acute on chronic hypoxic respiratory failure 12/31 discharged to home 01/02 hospitalization after hearing something "pop" near the groin area and associated SOB; Per patient stated that he woke up with increasing shortness of breath not improved with his nebulizer treatment. He also said that the night before had fever associated with chills, pain and swelling of his scrotum. At the hospital he was found to be tachycardic, tachypneic, febrile with initial labs showing white count of 21.0, lactic acid 1.4, BUN 38, creat 1.6, ABG with pH 7.451. bicarbonate 7.0 pCO2 38.7, PO2 49. 01/14 discharged from hospital 01/25 admitted to hospital w/ SOB; dx pneumonia and copd exacerbation 02/02 transferred to different hospital 02/18 COVID vaccine dose #1 02/18 discharged from hospital on hospice care 02/20 admitted to hospital via ambulance with diagnosis MI, noted that patient presented in asystole, then PEA, then ROSC 02/24 patient passed away
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pH increased, Blood urea increased, Cardiac arrest, Chills, Chronic obstructive pulmonary disease
Clinical narrative: Narrative:  Patient died after COVID vaccination dose #1. 11/06 hospitalization 12/20 hospitalization: COPD exacerbation with acute respiratory failure requiring bipap 12/29 hospitalization for SOB, acute on chronic hypoxic respiratory failure 12/31 discharged to home 01/02 hospitalization after hearing something "pop" near the groin area and associated SOB; Per patient stated that he woke up with increasing shortness of breath not improved with his nebulizer treatment. He also said that the night before had fever associated with chills, pain and swelling of his scrotum. At the hospital he was found to be tachycardic, tachypneic, febrile with initial labs showing white count of 21.0, lactic acid 1.4, BUN 38, creat 1.6, ABG with pH 7.451. bicarbonate 7.0 pCO2 38.7, PO2 49. 01/14 discharged from hospital 01/25 admitted to hospital w/ SOB; dx pneumonia and copd exacerbation 02/02 transferred to different hospital 02/18 COVID vaccine dose #1 02/18 discharged from hospital on hospice care 02/20 admitted to hospital via ambulance with diagnosis MI, noted that patient presented in asystole, then PEA, then ROSC 02/24 patient passed away
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Dyspnoea, PCO2 normal, PO2 decreased
Clinical narrative: Narrative:  Patient died after COVID vaccination dose #1. 11/06 hospitalization 12/20 hospitalization: COPD exacerbation with acute respiratory failure requiring bipap 12/29 hospitalization for SOB, acute on chronic hypoxic respiratory failure 12/31 discharged to home 01/02 hospitalization after hearing something "pop" near the groin area and associated SOB; Per patient stated that he woke up with increasing shortness of breath not improved with his nebulizer treatment. He also said that the night before had fever associated with chills, pain and swelling of his scrotum. At the hospital he was found to be tachycardic, tachypneic, febrile with initial labs showing white count of 21.0, lactic acid 1.4, BUN 38, creat 1.6, ABG with pH 7.451. bicarbonate 7.0 pCO2 38.7, PO2 49. 01/14 discharged from hospital 01/25 admitted to hospital w/ SOB; dx pneumonia and copd exacerbation 02/02 transferred to different hospital 02/18 COVID vaccine dose #1 02/18 discharged from hospital on hospice care 02/20 admitted to hospital via ambulance with diagnosis MI, noted that patient presented in asystole, then PEA, then ROSC 02/24 patient passed away
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Positive airway pressure therapy, Pulseless electrical activity, Pyrexia, Respiratory failure
Clinical narrative: Narrative:  Patient died after COVID vaccination dose #1. 11/06 hospitalization 12/20 hospitalization: COPD exacerbation with acute respiratory failure requiring bipap 12/29 hospitalization for SOB, acute on chronic hypoxic respiratory failure 12/31 discharged to home 01/02 hospitalization after hearing something "pop" near the groin area and associated SOB; Per patient stated that he woke up with increasing shortness of breath not improved with his nebulizer treatment. He also said that the night before had fever associated with chills, pain and swelling of his scrotum. At the hospital he was found to be tachycardic, tachypneic, febrile with initial labs showing white count of 21.0, lactic acid 1.4, BUN 38, creat 1.6, ABG with pH 7.451. bicarbonate 7.0 pCO2 38.7, PO2 49. 01/14 discharged from hospital 01/25 admitted to hospital w/ SOB; dx pneumonia and copd exacerbation 02/02 transferred to different hospital 02/18 COVID vaccine dose #1 02/18 discharged from hospital on hospice care 02/20 admitted to hospital via ambulance with diagnosis MI, noted that patient presented in asystole, then PEA, then ROSC 02/24 patient passed away
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Scrotal pain, Scrotal swelling, Tachycardia, Tachypnoea, White blood cell count increased
Clinical narrative: Narrative:  Patient died after COVID vaccination dose #1. 11/06 hospitalization 12/20 hospitalization: COPD exacerbation with acute respiratory failure requiring bipap 12/29 hospitalization for SOB, acute on chronic hypoxic respiratory failure 12/31 discharged to home 01/02 hospitalization after hearing something "pop" near the groin area and associated SOB; Per patient stated that he woke up with increasing shortness of breath not improved with his nebulizer treatment. He also said that the night before had fever associated with chills, pain and swelling of his scrotum. At the hospital he was found to be tachycardic, tachypneic, febrile with initial labs showing white count of 21.0, lactic acid 1.4, BUN 38, creat 1.6, ABG with pH 7.451. bicarbonate 7.0 pCO2 38.7, PO2 49. 01/14 discharged from hospital 01/25 admitted to hospital w/ SOB; dx pneumonia and copd exacerbation 02/02 transferred to different hospital 02/18 COVID vaccine dose #1 02/18 discharged from hospital on hospice care 02/20 admitted to hospital via ambulance with diagnosis MI, noted that patient presented in asystole, then PEA, then ROSC 02/24 patient passed away
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Device dependence, Dysphagia, Feeding tube user, Muscular weakness
Clinical narrative: Narrative: Patient was not previously Covid positive and did not have any predisposing fators(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 86 and had at least one year history of progressive muscle weakness and dysphagia requiring tube feed dependency. On 3/22/21 he went to the ER with pneumonia which he eventually passed away from on 4/7/2021. Comorbidities include chronic afib, HTN, HLD, CKD, asthma/COPD.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia
Clinical narrative: Narrative: Patient was not previously Covid positive and did not have any predisposing fators(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 86 and had at least one year history of progressive muscle weakness and dysphagia requiring tube feed dependency. On 3/22/21 he went to the ER with pneumonia which he eventually passed away from on 4/7/2021. Comorbidities include chronic afib, HTN, HLD, CKD, asthma/COPD.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Altered state of consciousness, Death, Neurological symptom, Unresponsive to stimuli
Clinical narrative: Narrative: Patient was not previously Covid Positive and did not have any predisposing facts (PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was a resident of the CLC and on 4/1/2021 he was having stroke like symptoms, not responding to stimuli, and apparent altered consciousness. He later passed that day. Patient had a PMH significant for systolic CHF, chronic indwelling foley, persistent Afib on Eliquis, COPD, CKD, OSA, and CVA
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Arteriosclerosis, Asthenia, Asthma, Cardiac failure congestive
Clinical narrative: Narrative:  Pt died after COVID vaccine dose #1 01/24 pt fell at home and was brought to ED, BP 200/100, bilateral legs/feet swollen, discharged on lasix and potassium x 5 days 02/15 COVID vaccine dose #1 02/17 pt seen by PCP, 'feeling very weak and not walking well, had several falls at home' 02/19 pt with fever 101.4 and diarrhea, chills, admitted to hospital, weakness and shortness of breath; CC: dyspnea/congestive heart failure and bilateral lower extremity edema CT of chest no pulmonary embolism, stable sternal dehiscence, moderate atherosclerotic calcifications, bilateral renal cysts. High troponins clinical impression moderate persistent asthma with acute exacerbation no status asthmaticus. 02/22 discharged from hospital: acute respiratory failure due to COPD, recurrent fall with deconditioning, chronic kidney disease stage III, sternal dehiscence, hyperglycemia; given rx for Combivent and Symbicort, 5 days of doxycycline and Mucinex 02/25 continued sob, on steroids 03/10 pt admitted to hospital, on ventilator due to pseudomonas infection 03/27 weaned from ventilator, sent to telemetry floor, suffered CVA, transferred to stroke facility, intubated and placed in ICU 04/03 pt passed away Vaccine not likely contributor to patient's death. Patient was hospitalized before and after vaccine with unstable medical condition. Never diagnosed with COVID. No ADR immediately after vaccine. Multiple contributors to death including advanced age and comorbidities.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Chills, Chronic kidney disease, Chronic obstructive pulmonary disease, Computerised tomogram thorax abnormal
Clinical narrative: Narrative:  Pt died after COVID vaccine dose #1 01/24 pt fell at home and was brought to ED, BP 200/100, bilateral legs/feet swollen, discharged on lasix and potassium x 5 days 02/15 COVID vaccine dose #1 02/17 pt seen by PCP, 'feeling very weak and not walking well, had several falls at home' 02/19 pt with fever 101.4 and diarrhea, chills, admitted to hospital, weakness and shortness of breath; CC: dyspnea/congestive heart failure and bilateral lower extremity edema CT of chest no pulmonary embolism, stable sternal dehiscence, moderate atherosclerotic calcifications, bilateral renal cysts. High troponins clinical impression moderate persistent asthma with acute exacerbation no status asthmaticus. 02/22 discharged from hospital: acute respiratory failure due to COPD, recurrent fall with deconditioning, chronic kidney disease stage III, sternal dehiscence, hyperglycemia; given rx for Combivent and Symbicort, 5 days of doxycycline and Mucinex 02/25 continued sob, on steroids 03/10 pt admitted to hospital, on ventilator due to pseudomonas infection 03/27 weaned from ventilator, sent to telemetry floor, suffered CVA, transferred to stroke facility, intubated and placed in ICU 04/03 pt passed away Vaccine not likely contributor to patient's death. Patient was hospitalized before and after vaccine with unstable medical condition. Never diagnosed with COVID. No ADR immediately after vaccine. Multiple contributors to death including advanced age and comorbidities.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Diarrhoea, Dyspnoea, Endotracheal intubation
Clinical narrative: Narrative:  Pt died after COVID vaccine dose #1 01/24 pt fell at home and was brought to ED, BP 200/100, bilateral legs/feet swollen, discharged on lasix and potassium x 5 days 02/15 COVID vaccine dose #1 02/17 pt seen by PCP, 'feeling very weak and not walking well, had several falls at home' 02/19 pt with fever 101.4 and diarrhea, chills, admitted to hospital, weakness and shortness of breath; CC: dyspnea/congestive heart failure and bilateral lower extremity edema CT of chest no pulmonary embolism, stable sternal dehiscence, moderate atherosclerotic calcifications, bilateral renal cysts. High troponins clinical impression moderate persistent asthma with acute exacerbation no status asthmaticus. 02/22 discharged from hospital: acute respiratory failure due to COPD, recurrent fall with deconditioning, chronic kidney disease stage III, sternal dehiscence, hyperglycemia; given rx for Combivent and Symbicort, 5 days of doxycycline and Mucinex 02/25 continued sob, on steroids 03/10 pt admitted to hospital, on ventilator due to pseudomonas infection 03/27 weaned from ventilator, sent to telemetry floor, suffered CVA, transferred to stroke facility, intubated and placed in ICU 04/03 pt passed away Vaccine not likely contributor to patient's death. Patient was hospitalized before and after vaccine with unstable medical condition. Never diagnosed with COVID. No ADR immediately after vaccine. Multiple contributors to death including advanced age and comorbidities.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Gait disturbance, General physical health deterioration, Hyperglycaemia, Intensive care
Clinical narrative: Narrative:  Pt died after COVID vaccine dose #1 01/24 pt fell at home and was brought to ED, BP 200/100, bilateral legs/feet swollen, discharged on lasix and potassium x 5 days 02/15 COVID vaccine dose #1 02/17 pt seen by PCP, 'feeling very weak and not walking well, had several falls at home' 02/19 pt with fever 101.4 and diarrhea, chills, admitted to hospital, weakness and shortness of breath; CC: dyspnea/congestive heart failure and bilateral lower extremity edema CT of chest no pulmonary embolism, stable sternal dehiscence, moderate atherosclerotic calcifications, bilateral renal cysts. High troponins clinical impression moderate persistent asthma with acute exacerbation no status asthmaticus. 02/22 discharged from hospital: acute respiratory failure due to COPD, recurrent fall with deconditioning, chronic kidney disease stage III, sternal dehiscence, hyperglycemia; given rx for Combivent and Symbicort, 5 days of doxycycline and Mucinex 02/25 continued sob, on steroids 03/10 pt admitted to hospital, on ventilator due to pseudomonas infection 03/27 weaned from ventilator, sent to telemetry floor, suffered CVA, transferred to stroke facility, intubated and placed in ICU 04/03 pt passed away Vaccine not likely contributor to patient's death. Patient was hospitalized before and after vaccine with unstable medical condition. Never diagnosed with COVID. No ADR immediately after vaccine. Multiple contributors to death including advanced age and comorbidities.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Mechanical ventilation, Multimorbidity, Oedema peripheral, Postoperative thoracic procedure complication, Pseudomonas infection
Clinical narrative: Narrative:  Pt died after COVID vaccine dose #1 01/24 pt fell at home and was brought to ED, BP 200/100, bilateral legs/feet swollen, discharged on lasix and potassium x 5 days 02/15 COVID vaccine dose #1 02/17 pt seen by PCP, 'feeling very weak and not walking well, had several falls at home' 02/19 pt with fever 101.4 and diarrhea, chills, admitted to hospital, weakness and shortness of breath; CC: dyspnea/congestive heart failure and bilateral lower extremity edema CT of chest no pulmonary embolism, stable sternal dehiscence, moderate atherosclerotic calcifications, bilateral renal cysts. High troponins clinical impression moderate persistent asthma with acute exacerbation no status asthmaticus. 02/22 discharged from hospital: acute respiratory failure due to COPD, recurrent fall with deconditioning, chronic kidney disease stage III, sternal dehiscence, hyperglycemia; given rx for Combivent and Symbicort, 5 days of doxycycline and Mucinex 02/25 continued sob, on steroids 03/10 pt admitted to hospital, on ventilator due to pseudomonas infection 03/27 weaned from ventilator, sent to telemetry floor, suffered CVA, transferred to stroke facility, intubated and placed in ICU 04/03 pt passed away Vaccine not likely contributor to patient's death. Patient was hospitalized before and after vaccine with unstable medical condition. Never diagnosed with COVID. No ADR immediately after vaccine. Multiple contributors to death including advanced age and comorbidities.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Renal cyst, Troponin increased
Clinical narrative: Narrative:  Pt died after COVID vaccine dose #1 01/24 pt fell at home and was brought to ED, BP 200/100, bilateral legs/feet swollen, discharged on lasix and potassium x 5 days 02/15 COVID vaccine dose #1 02/17 pt seen by PCP, 'feeling very weak and not walking well, had several falls at home' 02/19 pt with fever 101.4 and diarrhea, chills, admitted to hospital, weakness and shortness of breath; CC: dyspnea/congestive heart failure and bilateral lower extremity edema CT of chest no pulmonary embolism, stable sternal dehiscence, moderate atherosclerotic calcifications, bilateral renal cysts. High troponins clinical impression moderate persistent asthma with acute exacerbation no status asthmaticus. 02/22 discharged from hospital: acute respiratory failure due to COPD, recurrent fall with deconditioning, chronic kidney disease stage III, sternal dehiscence, hyperglycemia; given rx for Combivent and Symbicort, 5 days of doxycycline and Mucinex 02/25 continued sob, on steroids 03/10 pt admitted to hospital, on ventilator due to pseudomonas infection 03/27 weaned from ventilator, sent to telemetry floor, suffered CVA, transferred to stroke facility, intubated and placed in ICU 04/03 pt passed away Vaccine not likely contributor to patient's death. Patient was hospitalized before and after vaccine with unstable medical condition. Never diagnosed with COVID. No ADR immediately after vaccine. Multiple contributors to death including advanced age and comorbidities.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Fatigue, Limb discomfort, Oedema peripheral, Skin discolouration
Clinical narrative: Per non-clinic records, + history of DVT (3/2019 suffered acute LLE  DW with IVC filter placed), + history of GI bleed on heparin, small vessel CVA  Patient reported to local Hospital ER on 3 29/21 for evaluation of "worsening  dark discoloration on LLL" for the "last several weeks". US unable to show  definitive blood clots due to edema of lower extremity. Recommended to repeat  US in 5-7 days if continuing to have concerns. Recommended to elevate legs  frequently and f/u with wound care and PCP. On 4/15/21, Patient evaluated at  local Hospital ER d/t bilateral lower extremity edema. "ultrasound performed  prior to consultation shows no significant reflux in the superficial venous system  Chronic DVT was noted in bilateral femoral veins. In 2019 she suffered an acute  LLE DVT and an IVC filter was placed at that time. Since that time she has  experienced gradual worsening of the edema in her lower extremities. Symptoms  are more significant in the left lower extremity including heaviness and fatigue.  She is not on anticoagulation at this time. During consultation she denied pain,  achiness, restless legs, leg cramps, calf pain, chest pain, dyspnea or warmth in the  lower extremities. She does complain of bilateral lower extremity edema,  discoloration and skin thickening." Per ED Physician, 4/20, "Because of the  extensive nature of these DVTs she was encouraged to get a thrombectomy.  Thrombectomy was to be done as an outpatient and on a nonurgent basis. Patient  has an IVC filter and is not a candidate for anticoagulation as she has had a  massive GI bleed in the past per the patient. The patient denies chest pain or  shortness of breath
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Skin hypertrophy, Ultrasound Doppler abnormal
Clinical narrative: Per non-clinic records, + history of DVT (3/2019 suffered acute LLE  DW with IVC filter placed), + history of GI bleed on heparin, small vessel CVA  Patient reported to local Hospital ER on 3 29/21 for evaluation of "worsening  dark discoloration on LLL" for the "last several weeks". US unable to show  definitive blood clots due to edema of lower extremity. Recommended to repeat  US in 5-7 days if continuing to have concerns. Recommended to elevate legs  frequently and f/u with wound care and PCP. On 4/15/21, Patient evaluated at  local Hospital ER d/t bilateral lower extremity edema. "ultrasound performed  prior to consultation shows no significant reflux in the superficial venous system  Chronic DVT was noted in bilateral femoral veins. In 2019 she suffered an acute  LLE DVT and an IVC filter was placed at that time. Since that time she has  experienced gradual worsening of the edema in her lower extremities. Symptoms  are more significant in the left lower extremity including heaviness and fatigue.  She is not on anticoagulation at this time. During consultation she denied pain,  achiness, restless legs, leg cramps, calf pain, chest pain, dyspnea or warmth in the  lower extremities. She does complain of bilateral lower extremity edema,  discoloration and skin thickening." Per ED Physician, 4/20, "Because of the  extensive nature of these DVTs she was encouraged to get a thrombectomy.  Thrombectomy was to be done as an outpatient and on a nonurgent basis. Patient  has an IVC filter and is not a candidate for anticoagulation as she has had a  massive GI bleed in the past per the patient. The patient denies chest pain or  shortness of breath
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Narrative: Patient received a 3rd dose of Pfizer COVID vaccine inadvertently.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Decreased appetite, Fatigue, Feeling hot
Clinical narrative: Narrative: Yesterday, he received his second dose of COVID-19 vaccine. About 5 hours after receiving the vaccine, he noted onset of myalgias, headache and nausea. He has felt warm, had chills and slight sweating. He is tired and has no appetite. He reports coughing a few times yesterday, but has not coughed today. He has not had measured fever, vomiting, diarrhea, runny nose, sore throat, dyspnea or abdominal pain. No change in his senses of taste or smell.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Myalgia, Nausea
Clinical narrative: Narrative: Yesterday, he received his second dose of COVID-19 vaccine. About 5 hours after receiving the vaccine, he noted onset of myalgias, headache and nausea. He has felt warm, had chills and slight sweating. He is tired and has no appetite. He reports coughing a few times yesterday, but has not coughed today. He has not had measured fever, vomiting, diarrhea, runny nose, sore throat, dyspnea or abdominal pain. No change in his senses of taste or smell.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient received 1st covid moderna vaccine on 3/19/21 and 2nd dose on 4/16. Patient was found deceased at his home by local PD on 4/28/21. Cause of death has not been determined, no further details available at this time regarding how patient was found. Patient reported no side effects after 1st or 2nd dose of the vaccine. No prior history of COVID infection. Pt has a history of non-ischemic cardiomyopathy, atrial flutter/atrial fibrillation with cardioversion 7/12/2019@hospital, hypertension, OSA using CPAP, GERD, peripheral neuropathy, orthostatic hypotension, prior right DVT, hyperlipidemia, diabetes mellitus, CK-MB stage III and osteomyelitis with multiple amputations wheelchair-bound.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Electrocardiogram ST-T change, Electrocardiogram abnormal, Head discomfort, Headache
Clinical narrative: Narrative: 50yr patient received Moderna #1 then while waiting 15min developed sensation of tongue swelling and tingling over the anterior chest. EKG revealed non-specific ST/T wave changes (QTC 0.435) and tongue did appear to be swollen with mild hives. Given oxygen supplementation, 4 baby ASA and 911 called taken to local ER. Local ER visits #1 Summary: allergic reaction given Benadryl and Pepcid then sent home. Patient called telephone triage later same day to report sx returning (mild HA, chest tingling/numb, dizziness, head feels heavy). Triage told patient to call 911 which patient did present to a different ER. Local ER visit #2 unknown outcome.